Phase III trials at ESMO may change practice in several cancers
This article was originally published in Scrip
Executive Summary
Several of this year's most closely watched cancer drug trials will be presented at the upcoming European Society for Medical Oncology (ESMO) meeting in Milan on 8 October to 12 October.